Status:
COMPLETED
Atorvastatin and Sympathetic Activity in Chronic Kidney Disease
Lead Sponsor:
UMC Utrecht
Conditions:
Stable Chronic Kidney Disease
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Hypertensive chronic kidney disease (CKD) patients often have sympathetic hyperactivity which appears to contribute to the pathogenesis of hypertension and cardiovascular organ damage. Experimental st...
Detailed Description
see above
Eligibility Criteria
Inclusion
- stable chronic kidney disease
- Hypertension
Exclusion
- renal replacement therapy
- pregnancy
- diabetes mellitus
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
End Date :
July 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01257009
Start Date
August 1 2009
End Date
July 1 2010
Last Update
December 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center utrecht
Utrecht, Utrecht, Netherlands, 3584CX